7 th FIDSSA CONFERENCE 2017 Programme as at 11 May 2017 PROVISIONAL ACADEMIC PROGRAMME

Transcription

1 THURSDAY 9 NOVEMBER 15h00 17h00 Conference Registration FIDSSA Official Opening Ceremony 17h00 17h15 Welcome & Opening - Marc Mendelson (FIDSSA President) PLENARY SESSION 1: Emerging and Re-Emerging Infectious Diseases (In partnership with ISID) 17h15 17h45 17h45 18h15 18h15 18h45 19h00 21h00 Surveillance of Emerging & Re-Emerging Infectious Diseases African Viruses Flourishing in the Diaspora - Margheretta Isaacson Lecture The cost of delaying measles eradication Welcome Function & Trade Preview FRIDAY 10 NOVEMBER 07h00 07h45 Meet the Professor Meet the IPC Nursing Expert Breakfast Symposium Meet the Water expert: Breakfast session Quality of our drinking water, wider implications of water shortage in South Africa on the hospital environment PLENARY SESSION 2: Drug-Resistant Infections (In partnership with ESCMID) 08h00-08h30 08h30 09h00 09h00 09h30 09h30 10h00 10h00 10h30 TBD - IDSSA Neonatal Sepsis and drug-resistant infections Management of infections due to MDR Gram-negatives: towards individualised therapy One Health approach to drug-resistant infections

2 FRIDAY 10 NOVEMBER CONTINUED PARALLEL SESSION 1 10h30 12h30 Parallel 1: SASPID HIV & TB: Infants, co-infection, treatment failure Parallel 2: STDSSA New STI and BV management strategies Parallel 3: SASTM Shifting boundaries/ Overstepping boundaries Parallel 4: SASCM New Directions in Clinical Microbiology 1. Management of TB in neonates and young infants (25 mins) 2. Treatment of HIV/TB co-infection in children (25 mins) 3. Third line ART in children: how are we doing? (25 mins) 4. Research abstracts on HIV/TB topics or other Paediatric ID topics (3x 15 mins=45mins) STI prevalence in young men and women in KwaZulu Natal 2. STI and BV prevalence in young women in Cape Town and Soweto 3. New SA STI management guidelines (15 min) 4. Rapid/point-of-care diagnostic for STIs: Needs, progress and challenges (15 min) 5. GeneXpert for POC STI testing in South Africa (10 mins) 6. Cytokine biomarkers triage test for STIs and BV. 7. Behavioral modification to reduce STI incidence in adolescent women 1. Yellow fever (25mins) 2. Zoonosis (25mins) 3. Medical Tourism - beyond nip and tuck (25 mins) 4. Bytes and bites from Barcelona (25 mins) 1. Routine microbiome analysis in the clinical microbiology laboratory: now or never 2. Treatment of ESBL and carbapenemase-producing Enterobacteriaceae: a casebased discussion 3. Innovative Stewardship 4. Abstracts 12h30 13h30 LUNCH PANEL DISCUSSION: The way forward (40 min)

3 FRIDAY 10 NOVEMBER CONTINUED PLENARY SESSION 3: Managing infections in adolescents and pregnant women 13h30 14h00 14h00 14h30 14h30 15h00 15h00 15h30 The unique challenges of managing HIV in adolescents Adolescent Vaccination strategies Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa PARALLEL SESSION 2 15h30 17h30 Parallel 5: IDSSA New insights to viral hepatitis Parallel 6: ICSSA Control of the Environment for IPC Parallel 7: HIV Specific Challenges in HIV Management Parallel 8: Fungal Infections 17h30 18h30 18H30 19H15 1. New Update on Hep C 2. New National Hepatitis Treatment Strategy 3. Hepatitis E 4.TBC Society AGMs FIDSSA AGM 1. Impact of effective treatment on TB transmission, lack of impact of XDR treatment on transmission, problem of reducing transmission in treatment failures (30 min) 2. Limitations of natural ventilation and mechanical ventilation and room air cleaners in controlling airborne infection (30 min) 3. Environmental cleaning for persistent resistant organisms (30 min) 4. Importance of the Environment; and newer technologies for environmental disinfection (30 min) 1. Scaling up treatment for 7 million - the innovations required 2. Differentiated models of care: Afa- Perspective 3. Cardiovascular Disease in HIV 4. Current challenges of HIV research in children - where are the gaps while we wait for cure 1. Global emergence of Candida auris (20 mins) 2. Prevention and management of antifungal-resistant infection in the ICU (20 mins) 3. New antifungal treatment strategies for Cryptococcosisupdate from recent clinical trials (20 mins) 4. What s in the diagnostic pipeline for invasive mycoses? (20 mins) 5. Oral abstracts X 3 (10 min each) 19H30 INVITED FACULTY DINNER DELEGATES EVENING AT LEISURE

4 SATURDAY 11 NOVEMBER Quiz the Professor Sponsored Breakfast Symposium Sponsored Breakfast Symposium 07h00 08h00 Session for trainees- Quiz the Professors 4 panel Member discussion PLENARY SESSION 4 Spotlight on Infection Prevention 08h00 08h30 08h30 09h00 09h00 09h30 09h30 10h30 Determining infectiousness in transmission for TB patients UVGI: New SA Guidelines Prevention of Hospital-acquired infections POSTER PRESENTATIONS AND PARALLEL SESSION 3 Parallel 9: TB DR-TB- What s New? Parallel 10: Malaria / Tropical Parallel 11: Vaccines Parallel 12: Antimicrobial Research & Development (SAASP) 10h30 12h30 1. TB Nix- New treatment for XDR 2. A moving Target: Evolution of drug resistance in M. Tuberculosis 3. Treatment Monitoring, toxicity and tolerance 4. Access to new Drugs for DR-TB 1. Imported arboviruses in travellers: recognition, diagnosis & management 2.Malaria TBC 4.TBC 1. Pertussis 2. Role of evidence-based vaccinology in strengthening immunisation programs 3. TB Vaccine 4. Vaccines for Rheumatic Fever: The African connection 1. H3D - What s new in the antimicrobial R&D pipeline 2. Harnessing developing technology to combat drug resistance 3. New economic models for R&D: Lessons from DRIVE-AB 4. Re-vitalising the pipleline through the Global Antibiotic Research & Development Partnership (GARDP) 12h30 13h30 LUNCH

5 SATURDAY 11 NOVEMBER CONTINUED PLENARY SESSION 5 A Plenary Pot Pourri 13h30 14h00 14h00 14h30 14h30 15h00 15h00 15h30 The Genital Microbiome Stowaways: A One Health Perspective TBC PARALLEL SESSION 4 15h30 17h30 Parallel 13: Diagnostics/ new technologies for Infections Parallel 14: Management Systems in Rural Care Parallel 15: Antibiotic Stewardship interventions (open papers) (SAASP) Parallel 16: Maternal Infections 1. Urinary LAM 2. TB diagnostics 3. Emperors new clothes - Are point of Care diagnostics the next best thing? 4. TBC: GeneXpert for HPV 1. Austerity and Healthcare Delivery in Rural Areas: how do we set Priorities? Abstracts presentations 1. Maternal infections influence infant gut microbiota and immunity 2. Maternal Helminth infections 3. GBS during pregnancy 4. The vaginal microbiome during pregnancy and preterm delivery 5. Helminth infections during pregnancy ETHICS SESSION 17h45 18h15 Plenary 17 TBD 18h15 18h45 Plenary 18 TBD 18h45 Close of Conference 19h30 Social Event